iBio, Inc. (IBIO)
1.93
+0.22
(+12.87%)
USD |
NASDAQ |
Dec 31, 16:00
1.90
-0.03
(-1.55%)
After-Hours: 20:00
iBio Cash from Investing (Quarterly): -21.49M for Sept. 30, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Minerva Neurosciences, Inc. | 0.00 |
| Bionano Genomics, Inc. | -4.669M |
| Vor Biopharma, Inc. | -0.244M |
| Recursion Pharmaceuticals, Inc. | -2.549M |
| Senti Biosciences, Inc. | 0.00 |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -5.665M |
| Cash from Financing (Quarterly) | 46.70M |
| Free Cash Flow | -17.30M |
| Free Cash Flow Per Share (Quarterly) | -0.1075 |
| Free Cash Flow to Equity (Quarterly) | -5.483M |
| Free Cash Flow to Firm (Quarterly) | -5.661M |
| Free Cash Flow Yield | -40.57% |